as on November 22, 2025 at 1:40 am IST
Day's Low
Day's High
6.90%
Downside
1.38%
Upside
52 Week's Low
52 Week's High
4.48%
Downside
250.34%
Upside
Check Eledon Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$116.3M
EPS (TTM)
-0.63
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-36.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-95.49%
Compare market cap, revenue, PE, and other key metrics of Eledon Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $116.3M | NA | NA | 0.00% | |
| BUY | $42.6B | 410.98% | -16.34 | -264.83% | |
| BUY | $60.9B | 257.49% | 1439.88 | 1.36% | |
| BUY | $107.9B | 96.24% | 29.59 | 31.35% | |
| BUY | $74.5B | 42.08% | 16.84 | 32.13% |
The Eledon Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Eledon Pharmaceuticals Inc investment value today
Current value as on today
₹41,712
Returns
Returns from Eledon Pharmaceuticals Inc Stock
Dollar Returns*
₹6,085 (+6.09%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Eledon Pharmaceuticals Inc. Average target price of $8
Get share price movements and forecasts by analysts on Eledon Pharmaceuticals Inc.
What analysts predicted
81.88%UPSIDE
Target Price
$8
Current Price
$1.45
Analyzed by
12 Analysts
Target
$8.00
Eledon Pharmaceuticals Inc target price $8, a slight upside of 81.88% compared to current price of $1.45. According to 12 analysts rating.
Investment in Eledon Pharmaceuticals Inc Shares on INDmoney has grown by 1083.33% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:1083.33% versus previous 30 day period
Search interest for Eledon Pharmaceuticals Inc Stock has increased by 1062% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1062% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 07 November
Fri, 07:20 PM
-Eledon Pharmaceuticals stock drops 52.2% after Phase 2 trial fails to meet primary endpoint for tegoprubart.
Sat, 00:06 AM
-Despite Phase 2 failure, Eledon plans to advance tegoprubart into Phase 3 development.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 170.5% return, outperforming this stock by 236.3%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 954.6% return, outperforming this stock by 1000.7%
Price Dip
![]()
In the last 7 days, ELDN stock has moved down by -21.0%
| Organisation | Eledon Pharmaceuticals Inc |
| Headquarters | 19800 MacArthur Boulevard, Irvine, CA, United States, 92612 |
| CEO | Dr. David-Alexandre C. Gros M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. John Herberger | Vice President of Technical Operations |
Mr. Bryan E. Smith J.D. | General Counsel, Corporate Secretary & Chief Compliance Officer |
Dr. David Hovland Ph.D. | Chief Regulatory Officer |
Dr. Eliezer Katz F.A.C.S., FACS, M.D. | Chief Medical Officer |
Ms. Marina Escudero | VP & Head of Clinical Operations |
Dr. David-Alexandre C. Gros M.D., Ph.D. | CEO & Non Independent Director |
Dr. Steven N. Perrin Ph.D. | President, Chief Scientific Officer & Non Independent Director |
Mr. Paul Sean Little | Chief Financial Officer |
Eledon Pharmaceuticals Inc share price today is $1.45 as on . Eledon Pharmaceuticals Inc share today touched a day high of $1.47 and a low of $1.35.
Eledon Pharmaceuticals Inc share touched a 52 week high of $5.08 on and a 52 week low of $1.39 on . Eledon Pharmaceuticals Inc stock price today i.e. is trending at $1.45,which is 71.46% down from its 52 week high and 4.69% up from its 52 week low.
Eledon Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Eledon Pharmaceuticals Inc (ELDN) shares with as little as ₹89.642 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹896.42 in Eledon Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Eledon Pharmaceuticals Inc share’s latest price of $1.45 as on November 22, 2025 at 1:40 am IST, you will get 6.8966 shares of Eledon Pharmaceuticals Inc. Learn more about
fractional shares .